share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Mock James M

SEC announcement ·  Apr 9 16:13
Summary by Moomoo AI
Moderna's Chief Financial Officer, James M. Mock, completed a sale of 705 shares of the company's common stock on April 8, 2024. The transaction was executed at a price of $101.9281 per share, resulting in a total market value of $71,859.31. Prior to this sale, Mock had acquired 1,453 shares through the exercise of derivative securities on April 5, 2024. Following these transactions, Mock's direct holdings in Moderna amount to 5,048 shares. The sale represents an open market transaction, indicating a potential cash-in on the part of the CFO, while the acquisition reflects the exercise of options or similar securities.
Moderna's Chief Financial Officer, James M. Mock, completed a sale of 705 shares of the company's common stock on April 8, 2024. The transaction was executed at a price of $101.9281 per share, resulting in a total market value of $71,859.31. Prior to this sale, Mock had acquired 1,453 shares through the exercise of derivative securities on April 5, 2024. Following these transactions, Mock's direct holdings in Moderna amount to 5,048 shares. The sale represents an open market transaction, indicating a potential cash-in on the part of the CFO, while the acquisition reflects the exercise of options or similar securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more